Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods

Diagnostic Microbiology and Infectious Disease

Volumn 60, Issue 4, 2008, Pages 409-415

  Boyanova, Lyudmila ^a   Gergova, Galina ^a   Nikolov, Rossen ^b   Davidkov, Lubomir ^c   Kamburov, Victor ^d   Jelev, Christo ^e   Mitov, Ivan ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY HOSPITAL ST IVAN RILSKI   (Bulgaria)

^c UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^d Pirogov Emergency Hospital   (Bulgaria)

^e Department of Gastroenterology   (Bulgaria)

Author keywords

Adults; Agar dilution method; Amoxicillin; Breakpoint susceptibility testing; Children; Ciprofloxacin; Clarithromycin; E test; Evolution; Helicobacter; Metronidazole; Multidrug; Nitrofurantoin; Resistance; Tetracycline

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BISMUTH SALT; CIPROFLOXACIN; CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE; NITROFURANTOIN; OMEPRAZOLE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ADOLESCENT; ADULT; AGAR DILUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOPSY; CHILD; EPSILOMETER TEST; ERADICATION THERAPY; EVOLUTION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BULGARIA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 40749154835     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.11.008     Document Type: Article

References (33)

1. Alarcón T., de la Obra P., Domingo D., García-Campos J.A., Díaz-Regañón J., and López-Brea M. In vitro activity of furazolidone and nitrofurantoin in Helicobacter pylori clinical isolates and study of mutation rate. Rev. Esp. Quimioter. 18 (2005) 313-318
2. Baglan P.H., Bozdayi G., Ozkan M., Ahmed K., Bozdayi A.M., and Ozden A. Clarithromycin resistance prevalence and iceA gene status in Helicobacter pylori clinical isolates in Turkish patients with duodenal ulcer and functional dyspepsia. J. Microbiol. 44 (2006) 409-416
3. Boyanova L., Andreev N., Bouchard S., and Megraud F. Helicobacter pylori seroprevalence in Bulgaria. Med. Microbiol. Lett. 3 (1994) 107-113
4. Canton R., de Argila C.M., de Rafael L., and Baquero F. Antimicrobial resistance in Helicobacter pylori. Rev. Med. Microbiol. 12 (2001) 47-61
5. Chaves S., Gadanho M., Tenreiro R., and Cabrita J. Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test. J. Clin. Microbiol. 37 (1999) 1628-1631
6. Clinical and Laboratory Standard Institutes. Performance Standards for Antimicrobial Susceptibilities Testing: Sixteenth Informational Supplement. CLSI Document M100-S16 (2006), CLSI, Wayne, PA
7. De Francesco V., Margiotta M., Zullo A., Hassan C., Giorgio F., Burattini O., Stoppino G., Cea U., Pace A., Zotti M., Morini S., Panella C., and Ierardi E. Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J. Antimicrob. Chemother. 59 (2007) 783-785
8. Di Mario F., Cavallaro L.G., and Scarpignato C. 'Rescue' therapies for the management of Helicobacter pylori infection. Dig. Dis. 24 (2006) 113-130
9. Fischbach L., and Evans E.L. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment. Pharmacol. Ther. 26 (2007) 343-357
10. Gisbert J.P., Calvet X., Bujanda L., Marcos S., Gisbert J.L., and Pajares J.M. 'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures. Helicobacter 8 (2003) 90-94
11. Glocker E., Stueger H.P., and Kist M. Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob. Agents Chemother. 51 (2007) 346-349
12. Glupczynski Y., Megraud F., Lopez Brea M., and Andersen L.P. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 820-823
13. Hu C.T., Wu C.C., Lin C.Y., Cheng C.C., Su S.C., Tseng Y.H., and Lin N.T. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. J. Gastroenterol. Hepatol. 22 (2007) 720-723
14. Kim N., Kim J.M., Kim C.H., Park Y.S., Lee D.H., Kim J.S., Jung H.C., and Song I.S. Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea. J. Clin. Gastroenterol. 40 (2006) 683-687
15. Koletzko S., Richy F., Bontems P., Crone J., Kalach N., Monteiro M.L., Gottrand F., Celinska-Cedro D., Roma-Giannikou E., Oderda G., Kolacek S., Urruzuno P., Martinez Gomez M.J., Casswall T., Ashorn M., Bodanszky H., and Megraud F. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut 55 (2006) 1711-1716
16. Kwon D.H., Lee M., Kim J.J., Kim J.G., El-Zaatari F.A., Osato M.S., and Graham D.Y. Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance. Antimicrob. Agents Chemother. 45 (2001) 306-308
17. Kwon D.H., Dore M.P., Kim J.J., Kato M., Lee M., Wu J.Y., and Graham D.Y. High-level β-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 47 (2003) 2169-2178
18. Lawson A.J., Elviss N.C., and Owen R.J. Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales. J. Antimicrob. Chemother. 56 (2005) 282-286
19. Lopes A.I., Oleastro M., Palha A., Fernandes A., and Monteiro L. Antibiotic-resistant Helicobacter pylori strains in Portuguese children. Pediatr. Infect. Dis. J. 24 (2005) 404-409
20. Markova B., Proecska J., Benisheva T., Valcheva J., and Popova M. Antibiotic use and microbial resistance: data from the ESCMID projects EARSS and ESAC for Bulgaria. Proceedings of the 1st Conference of the Bulgarian Association of Medical Microbiology: Rational Antibiotic Policy. Sofia, Bulgaria (2005)
21. Masuda H., Hiyama T., Yoshihara M., Tanaka S., Haruma K., and Chayama K. Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade. Pathobiology 71 (2004) 159-163
22. Megraud F. H. pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53 (2004) 1374-1384
23. Megraud F., and Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin. Microbiol. Rev. 20 (2007) 280-322
24. Megraud F., Lehn N., Lind T., Bayerdorffer E., O'Morain C., Spiller R., Unge P., van Zanten S.V., Wrangstadh M., and Burman C.F. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob. Agents Chemother. 43 (1999) 2747-2752
25. Meyer J.M., Silliman N.P., Wang W., Siepman N.Y., Sugg J.E., Morris D., Zhang J., Bhattacharyya H., King E.C., and Hopkins R.J. Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann. Intern. Med. 136 (2002) 13-24
26. Morgner A., Labenz J., and Miehlke S. Effective regimens for the treatment of Helicobacter pylori infection. Expert Opin. Investig. Drugs 15 (2006) 995-1016
27. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Tenth Informational Supplement. Approved Standard M100-S10. M7 (2000), NCCLS, Wayne, PA
28. Peitz U., Sulliga M., Wolle K., Leodolter A., Von Arnim U., Kahl S., Stolte M., Borsch G., Labenz J., and Malfertheiner P. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol. Ther. 16 (2002) 315-324
29. Raymond J., Burucoa C., Pietrini O., Bergeret M., Decoster A., Wann A., Dupont C., and Kalach N. Clarithromycin resistance in Helicobacter pylori strains isolated from French children: prevalence of the different mutations and coexistence of clones harboring two different mutations in the same biopsy. Helicobacter 12 (2007) 157-163
30. Toracchio S., and Marzio L. Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002. Dig. Liver Dis. 35 (2003) 541-545
31. Watanabe K., Tanaka A., Imase K., Tokunaga K., Sugano H., Kai A., Ishida H., Itoh T., and Takahashi S. Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003. Helicobacter 10 (2005) 4-11
32. Ziemniak W. Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics. J. Physiol. Pharmacol. 57 Suppl 3 (2006) 123-1241
33. Zullo A., Perna F., Hassan C., Ricci C., Saracino I., Morini S., and Vaira D. Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol. Ther. 25 (2007) 1429-1434